MAPT and Alzheimer disease: The growing evidence demonstrates that plasmalogens can help to prevent some of AD progression through suppression of amyloid and tau accumulation, reducing neuroinflammation and activation of neurogenesis leading to significant improvement of cognitive and memory properties [53,197,198,199,200,201,202,203,204,205,206,207,208,209,210,211,212,213,214,215,216,217,218].